IL17A and systemic lupus erythematosus: Interestingly, SLE patients exhibited a higher proportion of Foxp3+ cells producers of IL-17, thus suggesting a possible Treg-Th17 trans-differentiation process that could be responsible for the reduced regulatory activity of Treg cells reported in SLE patients18.